Shu-Fang Wang Selected Research

Shu-Fang Wang Research Topics

Disease

8	Neoplasms (Cancer) 12/2020 - 12/2007
2	Wounds and Injuries (Trauma) 02/2015 - 04/2014
2	Leukemia 09/2007 - 04/2006
1	Thrombosis (Thrombus) 01/2022
1	Genomic Instability 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Rickets (Rachitis) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hyperplasia 01/2022
1	Colitis 06/2021
1	Ulcerative Colitis 06/2021
1	Inflammation (Inflammations) 06/2021
1	Pharyngitis (Sore Throat) 04/2021
1	Cough 04/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Carcinoma (Carcinomatosis) 12/2020
1	Periarthritis 11/2019
1	Glioma (Gliomas) 02/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018
1	Melanoma (Melanoma, Malignant) 02/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018
1	Prostatic Neoplasms (Prostate Cancer) 02/2018
1	Colorectal Neoplasms (Colorectal Cancer) 02/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2017
1	Carcinogenesis 01/2017
1	Shoulder Pain 01/2016
1	Iridocyclitis 07/2013
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2013
1	Pathologic Constriction (Stenosis) 06/2013
1	Infertility (Sterility) 05/2012
1	Neoplasm Metastasis (Metastasis) 06/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2008
1	Leiomyoma (Uterine Fibroids) 12/2007
1	Nephritis 04/2006

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2020 - 05/2012
2	LigandsIBA 06/2011 - 03/2011
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 06/2021
1	Dextrans (Dextran)FDA Link 06/2021
1	Peroxidase (Myeloperoxidase)IBA 06/2021
1	jie-geng-tangIBA 04/2021
1	glycyrrhizae radix et rhizomaIBA 04/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	aristolochic acid I (aristolochic acid)IBA 12/2020
1	kakkon-toIBA 11/2019
1	Proteoglycans (Proteoglycan)IBA 02/2018
1	3,3'- dioactadecyl- 5,5'- di(4- sulfophenyl)oxacarbocyanineIBA 10/2017
1	Therapeutic UsesIBA 10/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2015
1	CytokinesIBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015
1	A-factor (Streptomyces)IBA 02/2015
1	Hemoglobins (Hemoglobin)IBA 02/2015
1	Hemostatics (Antihemorrhagics)IBA 04/2014
1	yunnan baiyaoIBA 04/2014
1	XiongdankaimingIBA 07/2013
1	TabletsIBA 07/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2013
1	CalciumIBA 06/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2008
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 12/2007
1	Androgen Receptors (Androgen Receptor)IBA 12/2007
1	EnzymesIBA 12/2007
1	deoxyuridine triphosphateIBA 09/2007
1	anti-dsDNA autoantibodyIBA 04/2006
1	AutoantibodiesIBA 04/2006

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2019 - 07/2013
2	Therapeutics 06/2013 - 05/2012
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Stents 01/2022
1	Oral Administration 06/2021
1	Transplantation 01/2017
1	Cupping Therapy 01/2016
1	Blood Transfusion (Blood Transfusions) 02/2015
1	Lasers (Laser) 09/2012
1	Immunotherapy 03/2011